John Wilkin
Stock Analyst at Craig-Hallum
(1.31)
# 3,722
Out of 5,239 analysts
6
Total ratings
50%
Success rate
-0.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Buy | $12 → $10 | $3.71 | +169.54% | 2 | Mar 11, 2026 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $13.63 | +10.05% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $39.56 | +13.75% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $6.04 | +32.45% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $4.07 | +612.53% | 1 | Feb 12, 2025 |
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.71
Upside: +169.54%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $13.63
Upside: +10.05%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $39.56
Upside: +13.75%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $6.04
Upside: +32.45%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $4.07
Upside: +612.53%